Data Resource Profile: COVid VAXines Effects on the Aged (COVVAXAGE)
October 18, 2023
Resource Type
The 2022-2023 Lived Experience Panel Report, Voices of the Lived Experience Panel: Health Equity in Dementia Care and Research (English/Spanish)
October 3, 2023
Authors: María P. Aranda, PhD, MSW, MPA, LCSW, Talha Ali, Willetha Barnette, Bart Brammer, Katie Brandt, Roberta Cruz, Monica Downer, Shekinah Fashaw-Walters, Darrell Foss, Lupita Gutierrez-Parker, Ladson Hinton, MD, Freddye G. James, Gary Epstein-Lubow, MD, Carolyn Malone, MPH, Karen O. Moss, Katherine D. Peak, MPH, Judith S. Rocha
Description: This report summarizes the overarching themes that emerged during four meetings of the NIA IMPACT Collaboratory’s Lived Experience Panel, the Health Equity Team, and the Engaging Partners Team. The goal of these discussions was to learn about Panel members’ lived experiences and insights related to health equity in dementia care and research practices.
Read the full report here. Read the Spanish translated version here.
Citation: Aranda MP, Ali T, Barnette W, Brammer B, Brandt K, Cruz R, Downer M, Fashaw-Walters S, Foss D, Gutierrez-Parker L, Hinton L, James FG, Epstein-Lubow G, Malone C, Michael C, Moss K, Peak KD, Rocha JS. 2022-2023 Lived Experience Panel Report: Voices of the Lived Experience Panel: Health Equity in Dementia Care and Research. NIA IMPACT Collaboratory; 2023. doi: 10.58234/23680579
Health Equity LEP Report - English Version
Click to view Spanish LEP Report | Health Equity
Decision Architecture Randomization Trials: Extremely Low-Cost Trials with Preservation of Clinician and Patient Choice
September 2023 – In Grand Rounds 39, Dr. Flory introduces an innovative trial design known as Decision Architecture Randomization Trials (DART), which aims to utilize the 'decision architecture' of electronic health records to incorporate randomized nudges into various prescribing decisions.
Speaker
James Flory, MD, MSCE
Assistant Attending Physician
Endocrinology Service
Memorial Sloan Kettering Cancer Center
Learning Objectives
- Define ‘nudges’, ‘decision architecture’, and ‘A/B testing’.
- Describe a decision architecture randomization trial (DART).
- Understand how DART relates to other pragmatic clinical trial designs.
